Evidence map›Paper›PMID 41616083›Full record

ArticleThe Journal of infectious diseases2026

Dynamics of Intact and Defective Human Immunodeficiency Virus Type 1 (HIV-1) Proviruses During Decades of Suppressive Antiretroviral Treatment in Young Adults With Perinatal HIV.

Priya Khetan, Kunjal Patel, Wendy Yu, Joseph Szewczyk, Adit Dhummakupt, Sandra Burchett, Russell B Van Dyke, Deborah Persaud

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. The HIV Reservoir and Immune Landscape Across the Life Course of Women: Implications for Cure Strategies.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Priya KhetanDepartment of Pediatrics, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0001-5688-2071
Kunjal PatelDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.ORCID 0000-0003-0002-681X
Wendy YuCenter for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.ORCID 0000-0001-5967-2352
Joseph SzewczykDepartment of Pediatrics, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Adit DhummakuptDepartment of Pediatrics, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Sandra BurchettDepartment of Pediatrics, Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-7106-9262
Russell B Van DykeDepartment of Pediatrics, Section of Infectious Diseases, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Deborah PersaudDepartment of Pediatrics, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0001-5195-8743

Funding

PHACS - Data and Operations CenterU01HD052102 · NICHD · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI WILLIAMS, PAIGE L · 2005 to 2019
$242.7M
The Adolescent Master Protocol (AMP) Up Series ProjectP01HD103133 · NICHD · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI CHADWICK, ELLEN GOULD, HERNANDEZ-DIAZ, SONIA · 2020 to 2024
$88.3M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Anna Palmer Durbin · 2012 to 2026
$67.0M
LC - IMPAACT Leadership GroupUM1AI106716 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Grace M Aldrovandi · 2014 to 2026
$47.2M
Pediatric Adolescent Virus Elimination (PAVE) Martin Delaney CollaboratoryUM1AI164566 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Ann M Chahroudi, Deborah Persaud · 2021 to 2026
$35.5M
Deciphering Mechanisms of HIV Latency Reversal in Perinatal InfectionsR01AI150412 · NIAID · JOHNS HOPKINS UNIVERSITY · PI PERSAUD, DEBORAH · 2020 to 2023
$3.1M
Impact of Neonatal ART and Broadly Neutralizing Antibodies on HIV-1 Reservoirs in Infants: Towards ART-free RemissionR01AI186792 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Deborah Persaud · 2024 to 2026
$2.5M
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)Harvard T.H. Chan School of Public Health P01HD103133 and HD052102IMPAACT Lab Center NCT02720094 and NCT03164564IMPAACT Lab Center UM1AI106716Johns Hopkins Center for AIDS Research P30AI094189National Cancer Institute (NCI)National Heart, Lung, and Blood Institute (NHLBI)National Institute of Allergy and Infectious Diseases (NIAID)National Institute of Dental & Craniofacial Research (NIDCR)National Institute of Mental Health (NIMH)National Institute of Neurological Disorders and Stroke (NINDS)National Institute on Alcohol Abuse and Alcoholism (NIAAA)National Institute on Deafness and Other Communication Disorders (NIDCD)National Institute on Drug Abuse (NIDA)National Institutes of Health (OD)NIAID NIH HHS P30 AI094189NIAID NIH HHS R01 AI150412NIAID NIH HHS R01 AI186792NIAID NIH HHS UM1 AI106716NIAID NIH HHS UM1 AI164566NICHD NIH HHS P01 HD103133NICHD NIH HHS U01 HD052102NIH HHS AI150412, AI186792Pediatric Adolescent Virus Elimination (PAVE) UM1AI164566Pediatric HIV/AIDS Cohort Study (PHACS)Tulane University School of Medicine HD052104
6 · The paper itself

Abstract

backgroundUnderstanding HIV-1 reservoir dynamics during long-term antiretroviral therapy (ART) in youth with perinatal Human Immunodeficiency Virus Type-1 (HIV-1) is essential for ART-free remission strategies.

methodsWe quantified intact and defective HIV proviruses in 201 peripheral blood mononuclear cell samples (PBMCs) from participants ages 17.6-21.2 years in the Pediatric HIV/AIDS Cohort Study (PHACS) Adolescent Master Protocol. Participants were classified as early-suppressed (ES, <1 year of age at virologic suppression [VS]) or late-suppressed (LS, 1-5 years of age at VS) and had maintained VS for up to 20 years.

resultsTwenty-six participants (11 ES and 15 LS) were evaluated. Early-suppressed participants exhibited significantly lower intact HIV reservoirs compared with LS participants, with 67% of ES samples below detection limits (2.0 copies/106 PBMCs). By 5 years of VS, the ES participants had significantly lower mean intact proviral load (2.0 vs 6.6 copies/106 PBMCs) than LS participants, largely driven by faster clearance of intact proviruses in the first 5 years of VS. Among LS participants, females had larger intact reservoirs than males (mean: 12.5 vs 4.1 intact copies/106 PBMCs) and exhibited greater increases in defective proviruses over time.

conclusionsAchieving VS by 1 year of age in perinatal HIV infection results in substantially smaller HIV intact reservoirs by age 5, with effects sustained through young adulthood. Additionally, sex-based differences, larger intact reservoirs and increases in defective proviruses in females, underscore the need for tailored ART-free remission and cure strategies for this population.

Indexed as

Anti-HIV AgentsHIV-1HIV InfectionsProvirusesAdolescentCohort StudiesFemaleHumansLeukocytes, MononuclearMaleViral LoadYoung AdultAnti-HIV AgentsHIVperinatalproviral reservoiryoung adults

Identifiers

PMID41616083
PMCPMC13007499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.